fbpx
Medical Innovation Exchange

Roche scraps 5 trials while CEO admits Alzheimer's drug a 'high risk project'

https://www.fiercebiotech.com/biotech/roche-scraps-5-trials-while-ceo-admits-alzheimers-tigit-ambitions-remain-risky-bets

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.